Filing Flows › Sotera Health (SHC) › Q1 2025
Sotera Health (SHC) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 1, 2025
Sotera Health (SHC) reported revenue of $255M for the first quarter 2025 (Q1 2025), +3% from a year earlier and -12% from the quarter before. Operating margin was -5.8%, net loss $13.3M (5.2% of revenue).
Sotera Health, Q1 2025: revenue $255M (+3% year over year), operating margin -5.8%, net loss $13.3M, operating cash flow $55.5M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $255M | -12% | +3% |
| Operating profit | −$14.8M | — | — |
| Net earnings | −$13.3M | — | — |
| Operating cash flow | $55.5M | -0.4% | +472% |
| Free cash flow | $35.6M | — | — |
What changed
Revenue was $254.5M in Q1 2025, up 3% year over year and down 12% from the previous quarter. Sterigenics was the largest line at 67% of revenue. Nordion added $8.6M year over year (up 36%), 135% of the total change. Nelson Labs declined 9%.
Gross margin was 53.2%, up 2.0 points from a year earlier. Operating costs exceeded revenue by $14.8M, an operating margin of -5.8%. Operating expenses grew 103% against revenue growth of 3%. The fastest-growing cost line was Other operating costs (+454%). The quarter ended with a net loss of $13.3M, after a profit of $12.3M the previous quarter.
Operating cash flow was $55.5M (up 472% year over year). Non-cash charges added back $40.8M of depreciation and amortization and $7.2M of share-based compensation. Working capital and other items added $20.7M. Capital expenditures of $19.9M left free cash flow of $35.6M.
Questions
What was Sotera Health's revenue in the first quarter 2025?
Sotera Health (SHC) reported revenue of $255M for the first quarter 2025 (Q1 2025), +3% from a year earlier and -12% from the quarter before.
Was Sotera Health profitable in the first quarter 2025?
Operating loss was $14.8M (-5.8% of revenue) and net loss $13.3M.
Source: Sotera Health 10-Q on SEC EDGAR.